학술논문

Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis.
Document Type
Article
Source
Frontiers in Pharmacology; 2024, p01-11, 11p
Subject
PROTON pump inhibitors
CYCLIN-dependent kinase inhibitors
CYCLIN-dependent kinases
BREAST cancer
METASTATIC breast cancer
CANCER patients
EPIDERMAL growth factor receptors
CETUXIMAB
Language
ISSN
16639812
Abstract
Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)